We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $512.00. The ...

Shares of Elevance Health Inc. ELV rallied 1.11% to $435.68 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Guggenheim initiated coverage of Elevance Health (ELV) with a Buy rating and $518 price target The firm launched coverage on 11 healthcare ...

Marking an increase of 2.4%, the current average surpasses the previous average price target of $465.88. The standing of Elevance Health among ... per quarter for each stock).

Assess today's live Elevance Health Inc (ELV) share price, performance and insights using our live NYSE: ELV stock exchange data. Analyse the historical data and Elevance Health Inc share price ...